Literature DB >> 22484797

Comparison of the gut microbe profiles and numbers between patients with liver cirrhosis and healthy individuals.

Jianjun Liu1, Dachang Wu, Ayaz Ahmed, Xinli Li, Yufang Ma, Li Tang, Dianjun Mo, Yue Ma, Yi Xin.   

Abstract

Human liver was closely associated with gut through various biological mechanisms, such as bacterium-gut interactions. Alterations of gut microbiota seemed to play an important role in induction and promotion of liver damage progression. The aim of this study was to characterize the gut microbiota in liver cirrhosis patients and assess whether there are alterations in the diversity and similarity of intestinal flora in cirrhotic patients when compared with healthy individuals. PCR-denaturing gradient gel electrophoresis (DGGE) with universal primers targeting V3 region of the 16S rRNA gene was employed to characterize the overall intestinal microbiota composition, and some excised gel bands were cloned for sequencing. Real-time PCR was further utilized to quantitatively analyze the subpopulation of microbiota using group-specific primers targeting the Enterobacteriaceae, Enterococcus and Bifidobacterium genus. The DGGE profiles of two groups demonstrated significant differences between cirrhotic and healthy groups (P < 0.05). While real-time PCR revealed significant increase of Enterobacteriaceae and Enterococcus (P < 0.05) in the cirrhotic group compared with the healthy group. The ratio of Bifidobacterium genus and Enterobacteriaceae decreased in the cirrhotic patients group, but no statistical significance. This study revealed strong relationship between alterations of gut microbiota and liver cirrhosis.

Entities:  

Mesh:

Year:  2012        PMID: 22484797     DOI: 10.1007/s00284-012-0105-8

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  38 in total

Review 1.  DGGE/TGGE a method for identifying genes from natural ecosystems.

Authors:  G Muyzer
Journal:  Curr Opin Microbiol       Date:  1999-06       Impact factor: 7.934

Review 2.  Molecular ecological analysis of the gastrointestinal microbiota: a review.

Authors:  Erwin G Zoetendal; Chad T Collier; Satoshi Koike; Roderick I Mackie; H Rex Gaskins
Journal:  J Nutr       Date:  2004-02       Impact factor: 4.798

3.  Development of 16S rRNA-gene-targeted group-specific primers for the detection and identification of predominant bacteria in human feces.

Authors:  Takahiro Matsuki; Koichi Watanabe; Junji Fujimoto; Yukiko Miyamoto; Toshihiko Takada; Kazumasa Matsumoto; Hiroshi Oyaizu; Ryuichiro Tanaka
Journal:  Appl Environ Microbiol       Date:  2002-11       Impact factor: 4.792

Review 4.  The intestinal microbiota in health and disease: the influence of microbial products on immune cell homeostasis.

Authors:  Michael C Abt; David Artis
Journal:  Curr Opin Gastroenterol       Date:  2009-11       Impact factor: 3.287

5.  Real-time polymerase chain reaction quantification of specific butyrate-producing bacteria, Desulfovibrio and Enterococcus faecalis in the feces of patients with colorectal cancer.

Authors:  Ramadass Balamurugan; Ethendhar Rajendiran; Sarah George; G Vijay Samuel; Balakrishnan S Ramakrishna
Journal:  J Gastroenterol Hepatol       Date:  2008-07-08       Impact factor: 4.029

Review 6.  Pathogenesis of urinary tract infection--experimental studies of vaginal resistance to colonization.

Authors:  J Winberg; M Herthelius-Elman; R Möllby; C E Nord
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

7.  Roseburia intestinalis sp. nov., a novel saccharolytic, butyrate-producing bacterium from human faeces.

Authors:  Sylvia H Duncan; Georgina L Hold; Adela Barcenilla; Colin S Stewart; Harry J Flint
Journal:  Int J Syst Evol Microbiol       Date:  2002-09       Impact factor: 2.747

8.  Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation.

Authors:  R S Lin; F Y Lee; S D Lee; Y T Tsai; H C Lin; R H Lu; W C Hsu; C C Huang; S S Wang; K J Lo
Journal:  J Hepatol       Date:  1995-02       Impact factor: 25.083

9.  Obesity alters gut microbial ecology.

Authors:  Ruth E Ley; Fredrik Bäckhed; Peter Turnbaugh; Catherine A Lozupone; Robin D Knight; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-20       Impact factor: 11.205

10.  Gut reaction: environmental effects on the human microbiota.

Authors:  Melissa Lee Phillips
Journal:  Environ Health Perspect       Date:  2009-05       Impact factor: 9.031

View more
  20 in total

Review 1.  Probiotics and liver disease.

Authors:  Vishal Sharma; Shashank Garg; Sourabh Aggarwal
Journal:  Perm J       Date:  2013

2.  Gut microbe analysis between hyperthyroid and healthy individuals.

Authors:  Lei Zhou; Xinli Li; Ayaz Ahmed; Dachang Wu; Liang Liu; Juanjuan Qiu; Yao Yan; Meilan Jin; Yi Xin
Journal:  Curr Microbiol       Date:  2014-06-27       Impact factor: 2.188

Review 3.  The gut microbiota: A new potential driving force in liver cirrhosis and hepatocellular carcinoma.

Authors:  Marco Sanduzzi Zamparelli; Alba Rocco; Debora Compare; Gerardo Nardone
Journal:  United European Gastroenterol J       Date:  2017-05-08       Impact factor: 4.623

4.  Effect of probiotics and synbiotics consumption on serum concentrations of liver function test enzymes: a systematic review and meta-analysis.

Authors:  Saman Khalesi; David Wayne Johnson; Katrin Campbell; Susan Williams; Andrew Fenning; Sonia Saluja; Christopher Irwin
Journal:  Eur J Nutr       Date:  2017-11-08       Impact factor: 5.614

5.  Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation.

Authors:  Jasmohan S Bajaj; Phillip B Hylemon; Jason M Ridlon; Douglas M Heuman; Kalyani Daita; Melanie B White; Pamela Monteith; Nicole A Noble; Masoumeh Sikaroodi; Patrick M Gillevet
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-07-19       Impact factor: 4.052

Review 6.  Probiotics for people with hepatic encephalopathy.

Authors:  Rohan Dalal; Richard G McGee; Stephen M Riordan; Angela C Webster
Journal:  Cochrane Database Syst Rev       Date:  2017-02-23

Review 7.  Clinical and pathophysiological consequences of alterations in the microbiome in cirrhosis.

Authors:  Jane Macnaughtan; Rajiv Jalan
Journal:  Am J Gastroenterol       Date:  2015-09-29       Impact factor: 10.864

8.  Altered profile of human gut microbiome is associated with cirrhosis and its complications.

Authors:  Jasmohan S Bajaj; Douglas M Heuman; Phillip B Hylemon; Arun J Sanyal; Melanie B White; Pamela Monteith; Nicole A Noble; Ariel B Unser; Kalyani Daita; Andmorgan R Fisher; Masoumeh Sikaroodi; Patrick M Gillevet
Journal:  J Hepatol       Date:  2013-12-25       Impact factor: 25.083

Review 9.  The gut microbiota of nonalcoholic fatty liver disease: current methods and their interpretation.

Authors:  Niels van Best; Peter L Jansen; Sander S Rensen
Journal:  Hepatol Int       Date:  2015-06-12       Impact factor: 6.047

Review 10.  The Role of the Microbiome in Liver Cancer.

Authors:  Mar Moreno-Gonzalez; Naiara Beraza
Journal:  Cancers (Basel)       Date:  2021-05-12       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.